Abstract

BackgroundDurable efficacy of immune checkpoint blockade (ICB) occurred in a small number of patients with metastatic gastric cancer (mGC) and the determinant biomarker of response to ICB remains unclear.MethodsWe developed...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer
Yuezong Bai ... Shuang Tong
Journal for ImmunoTherapy of Cancer | VOL. 10
Yuezong Bai, et. al.Yuezong Bai ... Shuang Tong
01 Mar 2022
How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy
A Fundytus ... I.F Tannock
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 32
A Fundytus, et. al.A Fundytus ... I.F Tannock
08 Apr 2021
Understanding mechanisms of primary resistance to checkpoint inhibitors will lead to precision immunotherapy of advanced gastric cancer
V Gambardella ... A Cervantes
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 30
V Gambardella, et. al.V Gambardella ... A Cervantes
01 Mar 2019
Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer.
Jinchul Kim ... So Young Kang
Frontiers in Oncology | VOL. 10
Jinchul Kim, et. al.Jinchul Kim ... So Young Kang
13 Mar 2020
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Assessing the implications of sentinel lymph node removal in cervical cancer: an immunogenetic perspective – a SENTICOL ancillary study
Gaurav Thareja ... Alejandra Martinez
Journal for ImmunoTherapy of Cancer | VOL. 12
Gaurav Thareja, et. al.Gaurav Thareja ... Alejandra Martinez
15 Jul 2024
Novel insights into paclitaxel’s role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment
Yoonjeong Choi ... In-San Kim
Journal for ImmunoTherapy of Cancer | VOL. 12
Yoonjeong Choi, et. al.Yoonjeong Choi ... In-San Kim
15 Jul 2024
Cantharidin overcomes IL-2Rα signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species
Man Zhu ... Yanmin Zhang
Journal for ImmunoTherapy of Cancer | VOL. 12
Man Zhu, et. al.Man Zhu ... Yanmin Zhang
14 Jul 2024
A crisis in clinical research
David S Hong ... Mario Sznol
Journal for ImmunoTherapy of Cancer | VOL. 12
David S Hong, et. al.David S Hong ... Mario Sznol
11 Jul 2024
View more papers